Christopher Hennington, PhD accepts new patients on Medical News Today.
Christopher Hennington, PhD
Be the first to review this provider!
Lubbock, TX
Accepting new patients
Clinical Overview
Christopher Hennington, PhD works in Lubbock, TX as
Office Locations
-
Office4021 112th St, Lubbock, TX 79423
Patient Experience & Satisfaction
Be the first to leave a review
How likely are you to recommend Christopher Hennington?
Step 1 of 3
Your review of Christopher Hennington, PhD
50 characters remaining
1000 characters remaining
Was this a Telehealth appointment?
(This will display with your review)
Your email is used to confirm your review and will NOT appear in the review.
This name will appear with your review. If left blank, we'll use "Anonymous".
RVO Health property, Medical News Today, is owned by RVO Health. Please review our terms of use for more.
Help other patients find the right care by sharing a few more details about your visit.
Last step! Confirm your email.
We've sent an email to
Once you confirm, you can close this window.
Thank you for your review!
Your review has been confirmed and will be published after verification.
Thank you for your review!
We've sent a confirmation email. Your review will appear after you confirm it.
Please allow up to 30 seconds for the email to arrive. Don't see it? Make sure to check your 'spam' and 'updates' folder. Once you've confirmed your review, you can close this window.
Medical Expertise & Background
Specialties*
Counseling
- *Medical News Today does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.
Common Patient Questions
Christopher Hennington's office is located at 4021 112th St Lubbock, TX 79423. Get a map and directions to Christopher Hennington's office here.
Christopher Hennington does not have any reviews yet.
Claim Your Profile
Are you Christopher Hennington, PhD?
Know Before You Go
Preventive care: what doctors want you to know
Preventive care can help identify current or future health and medical concerns before they become major.
Featured Stories
"Myopia boom" refers to a predicted rise from 2.8 billion current cases worldwide to 4.8 billion by 2050. A recent study in shrew trees found that indigo light could help reduce the development of the eye condition.
With the Targeting Aging with Metformin (TAME) trial looking to secure funding, Medical News Today speaks to 2 experts to discuss how a decades-old diabetes drug may help scientists slow biological aging and delay diseases.
A new statement from the Endocrine Society suggests that obesity treatment success should focus on improvements in heart, metabolic, liver, sleep, mental, and physical health, not just weight loss.
